Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease - Concepedia

Concepedia

Publication | Closed Access

Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease

102

Citations

29

References

2014

Year

Monica Bhatia, Zhezhen Jin, Claire E. Baker, Mark B. Geyer, Kavita Radhakrishnan, Erin Morris, Prakash Satwani, D. George, James H. Garvin, G. Del Toro,

Bone Marrow Transplantation

Hematological MalignancyTranslational MedicineSickle Cell DiseasePediatric HematologyHematologyPediatricsReduced ToxicityMyeloablative ConditioningMedicine

References

	Year	Citations

Page 1

Page 1